CareTrust REIT to Announce Q4 Earnings on February 12

Written by Emily J. Thompson, Senior Investment Analyst

Source: seekingalpha

Updated: 4 days ago

0mins

CTRE-0.32%

Should l Buy CTRE?

Source: seekingalpha

Earnings Announcement: CareTrust REIT is set to release its Q4 earnings on February 12 after market close, with consensus estimates predicting a FFO of $0.47 and revenue of $130.45 million, indicating stable performance in the senior care sector.
Market Performance Insight: CareTrust REIT is viewed as a senior care portfolio worth holding, outperforming the S&P 500 despite macroeconomic uncertainties, showcasing its competitive edge and market appeal.
High Dividend Growth: The REIT is recognized for having the highest dividend growth grade among mid-cap stocks, reflecting a strong commitment to shareholder returns that may attract income-seeking investors.
Executive Appointments: The recent appointment of a new CFO and other executives aims to enhance management efficiency and strategic execution, potentially driving the company's long-term growth prospects.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy CTRE?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on CTRE

Wall Street analysts forecast CTRE stock price to fall

6 Analyst Rating

4 Buy

1 Hold

1 Sell

Moderate Buy

Current: 40.140

Low

28.00

Averages

31.80

High

35.00

Current: 40.140

Low

28.00

Averages

31.80

High

35.00

Citizens

Outperform

initiated

$44

2026-01-22

Reason

Citizens

Price Target

$44

AI Analysis

2026-01-22

initiated

Outperform

Reason

Citizens initiated coverage of CareTrust REIT with an Outperform rating and $44 price target. The firm believes the company's "outsized growth pace" will continue to drive shares higher. Citizens expects another "strong year of accretive acquisitions" for CareTrust and sees the stock as positioned to be re-rated for a higher multiple in the years to come.

BMO Capital

Market Perform -> Outperform

upgrade

$42 -> $43

2026-01-09

Reason

BMO Capital

Price Target

$42 -> $43

2026-01-09

upgrade

Market Perform -> Outperform

Reason

BMO Capital upgraded CareTrust REIT to Outperform from Market Perform with a price target of $43, up from $42. BMO adjusted real estate investment trust ratings as part of its 2026 outlook. The firm sees CareTrust's "accretive" acquisitions driving strong growth. It believes the company is benefitting from aging demographics with "minuscule" supply.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CTRE

Unlock Now

About CTRE

CareTrust REIT, Inc. is a self-administered real estate investment trust (REIT). The Company is engaged in the ownership, acquisition, development and leasing of skilled nursing, senior housing and other healthcare-related properties. It has a portfolio of long-term net-leased properties across the United States and United Kingdom. The Company owns, directly or indirectly through joint ventures, and leases to independent operators skilled nursing facilities (SNFs), multiservice campuses, assisted living facilities (ALFs) and independent living facilities (ILFs), consisting of operational beds and units located in various states with the highest concentration of properties by rental income located in California, Texas and Tennessee. Its facilities include Camarillo, San Juan Capistrano, Barton Creek, Bayshire Carlsbad, El Centro Post-Acute Care, Bayshire Rancho Mirage, Weiser Care, Wellspring Health and Rehabilitation of Cascadia, Cornerstone Rehab & Health Care Center, and others.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

CareTrust REIT Reports Transformational Q4 2025 Earnings

3 days agoseekingalpha

Significant Investment Growth: CareTrust REIT completed approximately $562 million in investments during Q4 2025, including its first SHOP deal, achieving a blended stabilized yield of 8.8%, demonstrating the company's strong capability in market expansion and portfolio enhancement.
Strong Financial Performance: The normalized FFO for Q4 reached $104.1 million, a 42.7% year-over-year increase, with FFO per share at $0.47, reflecting the company's sustained competitiveness and profitability in the market.
Optimistic Future Outlook: Management projects normalized FFO per share for 2026 to be between $1.90 and $1.95, indicating a 9.4% year-over-year growth rate, which underscores the company's confidence in future growth, particularly in the U.K. and SHOP sectors.
Increased Market Capitalization: In 2025, CareTrust's market capitalization grew by 61% to $8.2 billion, indicating a rising position within the industry and establishing a solid foundation for future investments and expansions.

CareTrust REIT Q4 Results Beat Expectations, 2026 Guidance Optimistic

3 days agoseekingalpha

Strong Earnings Report: CareTrust REIT reported Q4 FFO of $0.47, in line with expectations, while revenue reached $134.86 million, reflecting a 55.1% year-over-year increase and exceeding estimates by $4.41 million, indicating robust financial performance.
2026 Guidance: The company projects net income for 2026 to be approximately $1.45 to $1.50 per share, with normalized FFO and FAD expected to be around $1.90 to $1.95 per share, representing a 9.4% increase over 2025 results, showcasing confidence in future growth.
Solid Market Fundamentals: CEO Mr. Bunker emphasized that strong market fundamentals across all asset classes position the company well for continued growth and value creation, reflecting its competitive advantage in the industry.
Capital Deployment Capability: CareTrust has already deployed $214.8 million at the start of the year and has a $500 million pipeline, demonstrating its ability to capitalize on market opportunities and continue delivering compelling returns to shareholders.